BridgeBio Oncology Therapeutics Financial Overview
BridgeBio Oncology Therapeutics's market cap is currently $1.00B. The company's EPS TTM is $; its P/E ratio is -13.50; BridgeBio Oncology Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
